PTCT — PTC Therapeutics, Inc. stock price, charts and financials

QT49PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (NASDAQ: PTCT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
69.10
+0.99+1.45%
OverviewShort InterestFilings
PTCTQT49PTC Therapeutics, Inc.·NASDAQ
69.10+1.45%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20268-KCurrent report
Jul 30, 20264Statement of changes in beneficial ownership
Jul 30, 202610-QQuarterly report
Jul 30, 20263Initial statement of beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 16, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 05, 20268-KCurrent report
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 12, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
#1 / 25 of 450
Page
▼
/ 18